登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Alpha-Synuclein】

Alpha-Synuclein信息

英文名称:Synuclein alpha
中文名称:α-突触核蛋白
靶点别称:Truncated Alpha Synuclein,Α-Synuclein,Non-A Beta Component Of AD Amyloid,Synuclein Alpha-140,I+/--Synuclein,α-Synuclein,PARK4,PD1,alpha-Synuclein,Synuclein, Alpha (Non A4 Component Of Amyloid Precursor),Non A-Beta Component Of AD Amyloid,PARK1,SNCA,Synuclein Alpha,NACP,Parkinson Disease (Autosomal Dominant, Lewy Body) 4,Non-A4 Component Of Amyloid Precursor,Non A4 Component Of Amyloid Precursor
上市药物数量:0
临床药物数量:20
最高研发阶段:临床三期

Alpha-Synuclein分子别名

SNCA,NACP,PARK1,alpha-Synuclein

Alpha-Synuclein分子背景

Alpha-synuclein is a neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release. It acts also as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5. Abnormalities in alpha-synuclein are implicated in the pathogenesis of Parkinson's disease (PD). Alpha-synuclein is present in Lewy-bodies, the neuropathological hallmark of PD, and the protein and its aggregation have been widely linked to neurotoxic pathways that ultimately lead to neurodegeneration.

Alpha-Synuclein临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Buntanetap ANVS-405; ANVS-401 临床三期 Raptor Pharmaceutical 唐氏综合征, 慢性创伤性脑病, 帕金森病, 阿尔茨海默病, 轻度认知障碍, 额颞痴呆 详情
MEDI-1341 MEDI-1341; TAK- 341 临床二期 阿斯利康, Takeda Pharmaceutical Co Ltd 帕金森病, 多系统萎缩 详情
Lu AF-82422 (Lundbeck A/S) Lu AF-82422; Lu AF82422; Lu-AF82422 临床二期 灵北制药, Genmab A/S 帕金森病, 多系统萎缩 详情
Prasinezumab PRX-002; RG-7935; NEOD-002; RO-7046015 临床二期 Prothena 帕金森病 详情
Kenterin ENT-01; kenterin; Enterin-01 临床二期 Enterin Inc 便秘, 帕金森病, 痴呆 详情
UB-312 UB-312 临床二期 United Neuroscience Ltd 帕金森综合征, 帕金森病, 多系统萎缩 详情
PBT-434 PBT-434; ATH-434 临床二期 Prana Biotechnology Ltd 多系统萎缩 详情
MT101-5 MT101-5 临床二期 Mthera Pharma Co Ltd 帕金森病 详情
AMDX-2011P AMDX2011P; AMDX-2011P 临床二期 Amydis Inc 脑淀粉样血管病, 开角型青光眼, 帕金森病, 肌萎缩性侧索硬化 详情
ACI-7104 ACI-7104.056; ACI-7104 临床二期 Ac Immune Sa 帕金森病 详情
UCB-0599 UCB-1332; NPT200-11; UCB-0599 临床二期 Neuropore Therapies Inc, Novartis Ag 帕金森病 详情
ION-464 BIIB-101; IONIS-BIIB6 Rx; ION-464 临床一期 Ionis Pharmaceuticals Inc 多系统萎缩 详情
SAR-446159 ABL-301; SAR-446159 临床一期 Abl Bio Inc 帕金森病 详情
ACI-12589 ACI-12589; a-syn-PET tracer (AC Immune) 临床一期 Ac Immune Sa, 百健 帕金森病, 共核蛋白病 详情
SNP201 SNP201; SNP-201 临床一期 SciNeuro Pharmaceuticals 帕金森病 详情
[18F]UCB-2897 临床一期 Invicro Llc 帕金森综合征, 帕金森病, 多系统萎缩 详情
ACI-3847 ACI-3847; 18F-ACI-3847 临床一期 Ac Immune Sa, 百健 帕金森病, 神经变性疾病 详情
UCB-7853 UCB-7853 临床一期 Ucb Biopharma Srl 帕金森病 详情
Emrusolmin Anle-138b; TEV-56286 临床一期 Modag Gmbh 帕金森病 详情
Syneuro (Indus Biotech) 临床阶段不明 Indus Biotech Pvt Ltd 帕金森病 详情

消息提示

请输入您的联系方式,再点击提交!

确定